Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add filters








Language
Year range
1.
China Pharmacy ; (12): 85-89, 2018.
Article in Chinese | WPRIM | ID: wpr-704526

ABSTRACT

OBJECTIVE:To investigate the effectiveness and economy of Xinmailong injection combined with basic treatment plan in the treatment of heart failure with reduced left ventricular ejection fraction (HFREF).METHODS:In prospective randomized central group and open programmatic clinical trials,HFREF patients enrolled in 27 general hospitals during Feb.2014-Nov.2016 were divided into control group (n=253) and trial group (n=872) according to 1∶3.Control group received basic treatment,while trial group was additionally given Xinmailong injection intravenously for a treatment course (5 d) at least.Cost-effectiveness analysis was conducted from the perspective of the whole society by using the total response rate of cardiac functional grading,left ventricular ejection fraction (LVEF) improved data,Minnesota heart failure quality scale (MLHFQ) improved data and re-hospitalization rate.RESULTS:Total response rates of cardiac functional grading in control group and trial group were 61.54% and 81.06% in 3 months.The improved data of LVEF were about 3.05% and 7.35%;MLHFQ improved data were 24.39 and 26.63,and re-hospitalization rates were 19.43% and 10.02%.There were statistical significance in 2 groups (P<0.05),which indicated that clinical efficacy of trial group was better than that of control group.Pharmacoeconomics results showed that cost-effectiveness ratio of positive indicators as the improved data of LVEF and chronic cardiac insufficiency QOL scale (MLHFQ) in trial group were lower than control group (189.35 vs.243.46,576.38 vs.614.29).The cost-effectiveness ratio of re-hospitalization rate and fatality rate in trial group were higher than control group (2 019.61 vs.925.42).CONCLUSIONS:Xinmailong injection combined with basic treatment plan is better than basic treatment plan in the treatment of HFREF,and shows a better economy in cost-effectiveness analysis.

2.
Chinese Journal of Information on Traditional Chinese Medicine ; (12)2006.
Article in Chinese | WPRIM | ID: wpr-577356

ABSTRACT

0.05). Chuansu Jiuxin Capsule could improve haemorheology (mainly act on blood viscosity, plasma viscosity and HCT), degrade platelet function (increase TXB2 level and decrease 6-keto-PGF1? level) and protect endothelia (increase ET and decrease NO level). Conclusions Chuansu Jiuxin Capsule was effective and safe for the treatment on AP patients with syndrome of blood stasis in collateral of heart.

3.
China Journal of Traditional Chinese Medicine and Pharmacy ; (12)2005.
Article in Chinese | WPRIM | ID: wpr-679722

ABSTRACT

Objective:To supply the reliable evidence for a further research of the TCM syndrome of hyperuricemia and treating it with traditional Chinese medicine,we try to verification the risk factors and to research TCM syndrome differentiation for diagnosis in patients with hyperuricacidemia.Methods: We selected cases according to the standard of hyperuricacidemia's diagnose and adopted the method of retrospective and prospective analysis.Each of cases was investigated and filled in the form.These data were processed through statistical method in the end.Results: Clinical investigation selected 109 cases patients with hyperuricacidemia.First,male group incidence rate was higher than female.Second,incidence rate was increasing with age(r=0.826 p

4.
Chinese Journal of Rehabilitation Theory and Practice ; (12): 395-395, 2005.
Article in Chinese | WPRIM | ID: wpr-978148

ABSTRACT

@# ObjectiveTo observe the effect of Zhusuanhuoxue Prescription on asymptomatic Hyperuricemia with coronary heart disease.Methods26 subjects were randomly divided into two groups. 11 patients in the treatment group who were treated with Zhusuanhuoxue Prescription and 15 patients in the control group who were treated with Losartan 50 mg. The changes of the blood uric acid level were observed before and 3 weeks after treatment.ResultsThere was a significant difference of uric acid level before and after treatment(P<0.05), but there was no significant difference between these 2 groups(P=0.356).ConclusionZhusuanhuoxue Prescription is effective on asymptomatic hyperuricemia with CHD, which is similar to that of Lostan.

5.
Journal of Xi'an Jiaotong University(Medical Sciences) ; (6)1981.
Article in Chinese | WPRIM | ID: wpr-535407

ABSTRACT

Based on the histochemical observation ofnicotinamide adenine dinucleotide dehydrogenase(NADHD) and eytochrome oxidase (CCO) activi-ties of myocardium in cantharidine poisoned rats,furthermore, we observed the changes of these en-zymes of the myocardium cytochemically. The re-sult showed that, compared with control group, NADHD and CCO activities were inhibited afteradministration of cantharidin 1 or 2 h, and the in-hibition was found to be more obvious with poison-ing times prolonged, after 24 h, the cristae of mi-tochondria can not be distinguished, and the reac-tion products diffued into stroma to become a ho-mogeneous mass and lost their normal localization.It is indicated that cantharidin might destroy thestructure of mitochondria and interfere the activi-ties of NADHD and CCO of which both are locatedon mitochondria.

6.
Journal of Xi'an Jiaotong University(Medical Sciences) ; (6)1981.
Article in Chinese | WPRIM | ID: wpr-535373

ABSTRACT

In Cantharidin-poisoned rats, nicotinamide-adenine dinucletide dehydrogenase (NADHD) andcytochrome oxidase (CCO) activities of myocardi-um, stomach and intestine were observed in exper-iment histochemically. The result showed thatNADHD and CCO reaction granules were de-creased, stained weakly, and distributed sparselyin myocardium, stomach and intestine of intoxicat-ed rats as compared with the control group. Thus,from the experimental result it was considered thatcantharidin may inhibit the activities of NADHDand CCO in varving degrees.

SELECTION OF CITATIONS
SEARCH DETAIL